Raymond James Trust’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$366K Sell
2,046
-19
-0.9% -$3.3K 0.01% 932
2024
Q2
$337K Sell
2,065
-76
-4% -$12.3K 0.01% 917
2024
Q1
$374K Buy
2,141
+1
+0% +$164 0.01% 853
2023
Q4
$360K Buy
2,140
+8
+0.4% +$1.17K 0.01% 839
2023
Q3
$306K Buy
2,132
+2
+0.1% +$326 0.01% 855
2023
Q2
$392K Buy
2,130
+27
+1% +$4.42K 0.01% 773
2023
Q1
$335K Buy
2,103
+50
+2% +$7.68K 0.01% 817
2022
Q4
$279K Sell
2,053
-388
-16% -$54.3K 0.01% 865
2022
Q3
$282K Buy
2,441
+89
+4% +$12.1K 0.01% 819
2022
Q2
$285K Buy
2,352
+448
+24% +$56.3K 0.01% 824
2022
Q1
$271K Buy
1,904
+399
+27% +$56.6K 0.01% 937
2021
Q4
$265K Buy
+1,505
New +$251K 0.01% 960
2018
Q4
Sell
-5,330
Closed -$365K 880
2018
Q3
$365K Hold
5,330
0.02% 554
2018
Q2
$332K Buy
+5,330
New +$326K 0.02% 563

Other funds holding NOVT

Raymond James Trust's NOVT Position: Q3 2024 in Review

Raymond James Trust reduced its Novanta (NOVT) stake by 0.92% in Q3 2024, selling an estimated $3.3K and leaving 2,046 shares worth $366K. The position accounts for 0.01% of the portfolio, ranked #932.

Raymond James Trust first reported a position in NOVT in Q2 2018 and has held it in 14 quarters since. The position peaked at $392K in Q2 2023. 288 funds tracked by Wall St. Rank hold NOVT as of Q3 2024.

  • Raymond James Trust held 2,046 shares of Novanta worth $366K as of Q3 2024.
  • Raymond James Trust sold 19 Novanta shares in Q3 2024, an estimated $3.3K.
  • Novanta made up 0.01% of Raymond James Trust's portfolio in Q3 2024, its #932 holding.
  • Raymond James Trust first reported a position in Novanta in Q2 2018 and has held it in 14 quarters since.
  • Raymond James Trust's Novanta position peaked at $392K in Q2 2023.
  • 288 funds tracked by Wall St. Rank held Novanta as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.